Hikal informs about outcome of board meeting

06 May 2021 Evaluate
Hikal has informed that Board of Directors of the Company at its meeting held today i.e., May 06, 2021, considered, and approved: the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2021. The Audited Financial results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31, 2021 are enclosed in terms of Regulation 33 of SEBI (LODR) Regulations, 2015 together with Auditor's Report and the declaration of unmodified opinion; recommendation of Final Dividend for the financial year 2020-21 on equity share capital @ 50% [Re 1 per equity share, nominal value of Rs 2 each], aggregating to dividend of 100% (Rs 2 per equity share) {including Interim Dividend of Re 1 per share (50%) paid to the shareholders in the month of March, 2021, subject to the approval of shareholders in the ensuing Annual General Meeting (AGM). Final Dividend, if approved by the shareholders at the ensuing AGM, will be paid within 30 days of the AGM date; The appointment of Jai Hiremath (DIN: 00062203) Chairman & Managing Director of the Company as Executive Chairman with effective from October 1, 2021, subject to the approval of shareholders at the ensuing Annual General Meeting; and the appointment of Sameer Hiremath (DIN: 00062129), Joint Managing Director and CEO of the Company as Managing Director of the Company with effective from October 1, 2021, subject to the approval of shareholders at the ensuing Annual General Meeting. Also informed that that the trading window for trading in securities of the Company by Designated Persons will remain closed from April 1, 2021, till the end of 48 hours from the declaration of financial results of the Company for the quarter and financial year ended March 31, 2021, the trading window will re-open on Sunday, May 9, 2021.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

390.75 3.10 (0.80%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.